- Home
- Publications
- Publication Search
- Publication Details
Title
MRD in AML: The Role of New Techniques
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-23
DOI
10.3389/fonc.2019.00655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia
- (2019) V. Alfonso et al. LEUKEMIA
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Longitudinal detection of DNMT3A R882H transcripts in patients with acute myeloid leukemia
- (2018) Tiziana Ottone et al. AMERICAN JOURNAL OF HEMATOLOGY
- Role of minimal residual disease in the management of acute myeloid leukemia—a case-based discussion
- (2018) A. Coltoff et al. ANNALS OF HEMATOLOGY
- Consensus on MRD in AML?
- (2018) Elisabeth Paietta BLOOD
- Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
- (2018) Gerrit J. Schuurhuis et al. BLOOD
- Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group
- (2018) Yann Ferret et al. HAEMATOLOGICA
- Molecular Minimal Residual Disease in Acute Myeloid Leukemia
- (2018) Mojca Jongen-Lavrencic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia
- (2018) Francesco Buccisano et al. Expert Review of Hematology
- Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group
- (2018) Yann Ferret et al. HAEMATOLOGICA
- Is it time to routinely incorporate MRD into practice?
- (2018) Farhad Ravandi BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- The emerging role of measurable residual disease detection in AML in morphologic remission
- (2018) F. Buccisano et al. SEMINARS IN HEMATOLOGY
- Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives
- (2018) Fabio Forghieri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
- (2018) Uwe Platzbecker et al. LANCET ONCOLOGY
- CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia
- (2018) Wendelien Zeijlemaker et al. LEUKEMIA
- Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
- (2018) Rik A. Brooimans et al. LEUKEMIA RESEARCH
- Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia
- (2017) Claudia Brunetti et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
- (2017) Nuria Mencia-Trinchant et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Measurable residual disease testing in acute myeloid leukaemia
- (2017) C S Hourigan et al. LEUKEMIA
- Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
- (2017) J Flores-Montero et al. LEUKEMIA
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Myeloid Leukemia, Version 2.2013
- (2017) Margaret R. O’Donnell et al. Journal of the National Comprehensive Cancer Network
- Asymmetrical barcode adapter-assisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNA
- (2017) Jinwoo Ahn et al. Scientific Reports
- Current management of newly diagnosed acute promyelocytic leukemia
- (2016) L. Cicconi et al. ANNALS OF ONCOLOGY
- Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification
- (2016) Krishna V. Komanduri et al. Annual Review of Medicine
- Is there justification for 4 cycles of consolidation therapy in AML?
- (2016) Richard F. Schlenk BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia
- (2016) Prisca Theunissen et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Isocitrate dehydrogenase mutations in myeloid malignancies
- (2016) B C Medeiros et al. LEUKEMIA
- Assessment of Minimal Residual Disease in Standard-Risk AML
- (2016) Adam Ivey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- MRD in AML: does it already guide therapy decision-making?
- (2016) G. Ossenkoppele et al. Hematology-American Society of Hematology Education Program
- MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
- (2016) Maria Ilaria Del Principe Mediterranean Journal of Hematology and Infectious Diseases
- A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia
- (2015) D. F. Angelini et al. CLINICAL CANCER RESEARCH
- Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
- (2015) C. Willekens et al. HAEMATOLOGICA
- Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia
- (2015) Jeffery M. Klco et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia
- (2015) W Zeijlemaker et al. LEUKEMIA
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
- (2015) Houria Debarri et al. Oncotarget
- Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis
- (2015) Thomas McKerrell et al. Cell Reports
- Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial
- (2015) C. Willekens et al. HAEMATOLOGICA
- Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?
- (2014) D. Grimwade et al. BLOOD
- Quantification of rareNPM1mutation subtypes by digital PCR
- (2014) Ulrike Bacher et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials
- (2014) D. A. Pollyea et al. HAEMATOLOGICA
- DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies
- (2014) A P Im et al. LEUKEMIA
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
- (2013) J. Kronke et al. BLOOD
- Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
- (2013) E. Jourdan et al. BLOOD
- Next-generation sequencing - feasibility and practicality in haematology
- (2013) Alexander Kohlmann et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identification of emergingFLT3ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin
- (2013) Tiziana Ottone et al. BRITISH JOURNAL OF HAEMATOLOGY
- Tumor heterogeneity makes AML a “moving target” for detection of residual disease
- (2013) W. Zeijlemaker et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia
- (2013) Sylvie D. Freeman et al. JOURNAL OF CLINICAL ONCOLOGY
- Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission
- (2013) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
- (2013) Monique Terwijn et al. JOURNAL OF CLINICAL ONCOLOGY
- Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease
- (2013) A Kohlmann et al. LEUKEMIA
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
- (2012) J. A. L. Yin et al. BLOOD
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia
- (2012) A. Nazha et al. HAEMATOLOGICA
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
- (2012) Jan J. Cornelissen et al. Nature Reviews Clinical Oncology
- Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes
- (2012) K. Shiroguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Counting absolute numbers of molecules using unique molecular identifiers
- (2011) Teemu Kivioja et al. NATURE METHODS
- Towards individualized follow-up in adult acute myeloid leukemia in remission
- (2010) P. Hokland et al. BLOOD
- Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia
- (2010) F. Buccisano et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Prognostic Impact of Minimal Residual Disease inCBFB-MYH11–Positive Acute Myeloid Leukemia
- (2010) Andrea Corbacioglu et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
- Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML
- (2010) F Dicker et al. LEUKEMIA
- Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
- (2009) S. Schnittger et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
- (2009) John Koreth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by StandardizedWT1Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
- (2009) Daniela Cilloni et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy
- (2009) David Grimwade et al. JOURNAL OF CLINICAL ONCOLOGY
- Independent prognostic factors for AML outcome
- (2009) D. Grimwade et al. Hematology-American Society of Hematology Education Program
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
- (2008) Timothy J. Ley et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now